Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7603)	10/31/1998 9:20:00 AM
From: Robert K.	Respond to of 17367

As a follow-on to my last post I choose to recite (again) on of my favorite medline article. Horwitz. Think in context on the lbp diagnostic and its utility. >http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7822017&form=6&db=m&Dopt=b

To: aknahow who wrote (7603)	11/1/1998 9:07:00 AM
From: Robert K.	Read Replies (3) \| Respond to of 17367

AND..........Look at ALL the OTHER "sepsis" drugs and what did they try to accomplish in that "probable" pathway. Antril (anti-IL-1) Anti-TNF E5 Ha1a ENP E55whatever TPA antibiotics etc,etc...... I think all "Basically"single interventions in the pathway. Will any single agent work? Will any combo work? Will bpi work? I apologize in advance for partial list of drugs above and poor research on my part if I am wrong, but I am just trying to get a point across. As always all IMO, all disclaimers. Consider all as worthless and unknowledgable info. Do your own research etc,etc...